The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Acute Lymphoblastic Leukemia in Children
Abstract
The most common cancer in childhood is now curable in 90% of patients. Current efforts are focused on devising molecular-based therapy for the subsets of acute lymphoblastic leukemia that are most resistant to current therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
US Department of Health and Human Services; National Cancer Institute (1999) · PsycEXTRA Dataset · doi:10.1037/e407432005-001 · Cited by 1,947
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Self-citationThe genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citationDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
Self-citationTargetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y.-L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403088 · Cited by 1,377
Self-citationTopp, M. S., Gökbuget, N., Stein, A. S., Zugmaier, G., O'Brien, S., Bargou, R. C., Dombret, H., Fielding, A. K., Heffner, L., Larson, R. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71170-2 · Cited by 1,269
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Self-citationAversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Self-citationOutcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Self-citationPrognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
van Dongen, J. J., Seriu, T., Panzer-Grümayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04058-6 · Cited by 952
Den Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 901
Borowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S., Martin, P. L., Pullen, D. J., Viswanatha, D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 842
Self-citationGenomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Self-citationConter, V., Bartram, C. R., Valsecchi, M. G., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Aricò, M., Zimmermann, M., Mann, G., De Rossi, G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-248146 · Cited by 785
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Cavé, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B., Vilmer, E., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390904 · Cited by 768
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 731
Self-citationRoss, D. M., Branford, S., Seymour, J. F., Schwarer, A. P., Arthur, C., Yeung, D. T., Dang, P., Goyne, J. M., Slader, C., Filshie, R. J., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483750 · Cited by 710
Schultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2514 · Cited by 701
Self-citationPrenatal origin of acute lymphoblastic leukaemia in children
Wiemels, J., Cazzaniga, G., Daniotti, M., Eden, O., Addison, G., Masera, G., Saha, V, Biondi, A., & Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)09403-9 · Cited by 654
Trends in childhood cancer incidence in the U.S. (1992–2004)
Linabery, A. M., & Ross, J. A. (2008) · Cancer · doi:10.1002/cncr.23169 · Cited by 643
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Self-citationNguyen, K., Devidas, M., Cheng, S.-C., La, M., Raetz, E. A., Carroll, W. L., Winick, N. J., Hunger, S. P., Gaynon, P. S., Loh, M. L., et al. (2008) · Leukemia · doi:10.1038/leu.2008.251 · Cited by 582
Self-citationHarvey, R. C., Mullighan, C. G., Chen, I.-M., Wharton, W., Mikhail, F. M., Carroll, A. J., Kang, H., Liu, W., Dobbin, K. K., Smith, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245944 · Cited by 574
Self-citationGermline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
Self-citationRussell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Evans, W. E., Relling, M. V., Rodman, J. H., Crom, W. R., Boyett, J. M., & Pui, C.-H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380803 · Cited by 492
The MLL recombinome of acute leukemias in 2013
Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., et al. (2013) · Leukemia · doi:10.1038/leu.2013.135 · Cited by 491
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
for The St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Andersson, A. K., Ma, J., Wang, J., Chen, X., Gedman, A. L., Dang, J., Nakitandwe, J., Holmfeldt, L., Parker, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3230 · Cited by 490
Self-citationClinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Sancho, J., Hancock, M. L., Boyett, J. M., Behm, F. G., Raimondi, S. C., Sandlund, J. T., Rivera, G. K., Rubnitz, J. E., Ribeiro, R. C., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2691 · Cited by 484
Papaemmanuil, E., Hosking, F. J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., Kinsey, S. E., Lightfoot, T., Roman, E., Irving, J. A. E., et al. (2009) · Nature Genetics · doi:10.1038/ng.430 · Cited by 482
Vora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., & Richards, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70600-9 · Cited by 478
Schultz, K. R., Carroll, A., Heerema, N. A., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Zheng, H. W., Davies, S. M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.30 · Cited by 447
Self-citationImmunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
Coustan-Smith, E., Behm, F. G., Sanchez, J., Boyett, J. M., Hancock, M. L., Raimondi, S. C., Rubnitz, J. E., Rivera, G. K., Sandlund, J. T., Pui, C.-H., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10295-1 · Cited by 447
Nachman, J. B., Sather, H. N., Sensel, M. G., Trigg, M. E., Cherlow, J. M., Lukens, J. N., Wolff, L., Uckun, F. M., & Gaynon, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382304 · Cited by 445
Schrappe, M., Valsecchi, M. G., Bartram, C. R., Schrauder, A., Panzer-Grümayer, R., Möricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., et al. (2011) · Blood · doi:10.1182/blood-2011-03-338707 · Cited by 435
Molecular pathogenesis of T-cell leukaemia and lymphoma
Aifantis, I., Raetz, E., & Buonamici, S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2304 · Cited by 428
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Faham, M., Zheng, J., Moorhead, M., Carlton, V. E. H., Stow, P., Coustan-Smith, E., Pui, C.-H., & Campana, D. (2012) · Blood · doi:10.1182/blood-2012-07-444042 · Cited by 423
High incidence of secondary brain tumours after radiotherapy and antimetabolites
Relling, M. V., Rubnitz, J. E., Rivera, G. K., Boyett, J. M., Hancock, M. L., Felix, C. A., Kun, L. E., Walter, A. W., Evans, W. E., & Pui, C.-H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11079-6 · Cited by 411
Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
Relling, M. V., Hancock, M. L., Boyett, J. M., Pui, C.-H., & Evans, W. E. (1999) · Blood · doi:10.1182/blood.v93.9.2817 · Cited by 395
Moorman, A. V., Ensor, H. M., Richards, S. M., Chilton, L., Schwab, C., Kinsey, S. E., Vora, A., Mitchell, C. D., & Harrison, C. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70066-8 · Cited by 390
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Zhang, M. Y., Churpek, J. E., Keel, S. B., Walsh, T., Lee, M. K., Loeb, K. R., Gulsuner, S., Pritchard, C. C., Sanchez-Bonilla, M., Delrow, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3177 · Cited by 367
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
Kaufmann, S. H., Karp, J. E., Svingen, P. A., Krajewski, S., Burke, P. J., Gore, S. D., & Reed, J. C. (1998) · Blood · doi:10.1182/blood.v91.3.991 · Cited by 365
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Söderhäll, S., Taskinen, M., & On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010) · Leukemia · doi:10.1038/leu.2009.251 · Cited by 365
Kuiper, R. P., Schoenmakers, E. F. P. M., van Reijmersdal, S. V., Hehir-Kwa, J. Y., van Kessel, A. G., van Leeuwen, F. N., & Hoogerbrugge, P. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404691 · Cited by 365
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
Ma, X., Edmonson, M., Yergeau, D., Muzny, D. M., Hampton, O. A., Rusch, M., Song, G., Easton, J., Harvey, R. C., Wheeler, D. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7604 · Cited by 357
Self-citationCentral Nervous System Therapy and Combination Chemotherapy of Childhood Lymphocytic Leukemia
AUR, R. J. A., SIMONE, J., HUSTU, H. O., WALTERS, T., BORELLA, L., PRATT, C., & PINKEL, D. (1971) · Blood · doi:10.1182/blood.v37.3.272.272 · Cited by 357
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Tzoneva, G., Perez-Garcia, A., Carpenter, Z., Khiabanian, H., Tosello, V., Allegretta, M., Paietta, E., Racevskis, J., Rowe, J. M., Tallman, M. S., et al. (2013) · Nature Medicine · doi:10.1038/nm.3078 · Cited by 350
Amylon, M., Shuster, J., Pullen, J., Berard, C., Link, M., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401310 · Cited by 347
Krull, K. R., Brinkman, T. M., Li, C., Armstrong, G. T., Ness, K. K., Srivastava, D. K., Gurney, J. G., Kimberg, C., Krasin, M. J., Pui, C.-H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2315 · Cited by 343
Dördelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.-D., Götz, N., Viehmann, S., Gadner, H., Riehm, H., & Schrappe, M. (1999) · Blood · doi:10.1182/blood.v94.4.1209 · Cited by 341
DeAngelo, D. J., Stevenson, K. E., Dahlberg, S. E., Silverman, L. B., Couban, S., Supko, J. G., Amrein, P. C., Ballen, K. K., Seftel, M. D., Turner, A. R., et al. (2015) · Leukemia · doi:10.1038/leu.2014.229 · Cited by 330
Biondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70377-7 · Cited by 330
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C., Wechsler, J., Yang, J., Hayes, J., Klein, R. J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2754 · Cited by 327
Self-citationVrooman, L. M., Stevenson, K. E., Supko, J. G., O'Brien, J., Dahlberg, S. E., Asselin, B. L., Athale, U. H., Clavell, L. A., Kelly, K. M., Kutok, J. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2070 · Cited by 315
PHF6 mutations in T-cell acute lymphoblastic leukemia
Van Vlierberghe, P., Palomero, T., Khiabanian, H., Van der Meulen, J., Castillo, M., Van Roy, N., De Moerloose, B., Philippé, J., González-García, S., Toribio, M. L., et al. (2010) · Nature Genetics · doi:10.1038/ng.542 · Cited by 310
Association of CYP 3 A 4 genotype with treatment-related leukemia
Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N.-K. V., Lovett, B. D., Nowell, P. C., Blair, I. A., & Rebbeck, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13176 · Cited by 310
Perez-Andreu, V., Roberts, K. G., Harvey, R. C., Yang, W., Cheng, C., Pei, D., Xu, H., Gastier-Foster, J., E, S., Lim, J. Y.-S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2803 · Cited by 305
Self-citationLarson, R. A., Wang, Y., Banerjee, M., Wiemels, J., Hartford, C., Beau, M. M. L., & Smith, M. T. (1999) · Blood · doi:10.1182/blood.v94.2.803 · Cited by 304
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304
Vora, A., Goulden, N., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., Moorman, A. V., & Wade, R. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70243-8 · Cited by 302
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Meyer, J. A., Wang, J., Hogan, L. E., Yang, J. J., Dandekar, S., Patel, J. P., Tang, Z., Zumbo, P., Li, S., Zavadil, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2558 · Cited by 297
Self-citationMahoney, D. H., Shuster, J. J., Nitschke, R., Lauer, S. J., Steuber, C. P., Winick, N., & Camitta, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1712 · Cited by 290
Zhang, J., Mullighan, C. G., Harvey, R. C., Wu, G., Chen, X., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I.-M., Devidas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341412 · Cited by 277
Self-citationWalter, A. W., Hancock, M. L., Pui, C. H., Hudson, M. M., Ochs, J. S., Rivera, G. K., Pratt, C. B., Boyett, J. M., & Kun, L. E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.12.3761 · Cited by 275
Polymorphism of the thiopurine S-methyltransferase gene in African- Americans
Hon, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.371 · Cited by 271
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
Kuiper, R. P., Waanders, E., van der Velden, V. H. J., van Reijmersdal, S. V., Venkatachalam, R., Scheijen, B., Sonneveld, E., van Dongen, J. J. M., Veerman, A. J. P., van Leeuwen, F. N., et al. (2010) · Leukemia · doi:10.1038/leu.2010.87 · Cited by 268
Pallisgaard, N., Hokland, P., Riishøj, D. C., Pedersen, B., & Jørgensen, P. (1998) · Blood · doi:10.1182/blood.v92.2.574 · Cited by 263
Buitenkamp, T. D., Izraeli, S., Zimmermann, M., Forestier, E., Heerema, N. A., van den Heuvel-Eibrink, M. M., Pieters, R., Korbijn, C. M., Silverman, L. B., Schmiegelow, K., et al. (2014) · Blood · doi:10.1182/blood-2013-06-509463 · Cited by 248
Self-citationVeerman, A. J., Kamps, W. A., van den Berg, H., van den Berg, E., Bökkerink, J. P., Bruin, M. C., van den Heuvel-Eibrink, M. M., Korbijn, C. M., Korthof, E. T., van der Pal, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70228-1 · Cited by 245
Pieters, R., den Boer, M., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G., van Wering, E., & Veerman, A. (1998) · Leukemia · doi:10.1038/sj.leu.2401129 · Cited by 245
Aricò, M., Schrappe, M., Hunger, S. P., Carroll, W. L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1325 · Cited by 240
Self-citationLúcio, P., Parreira, A., van den Beemd, M., van Lochem, E., van Wering, E., Baars, E., Porwit-MacDonald, A., Bjorklund, E., Gaipa, G., Biondi, A., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401279 · Cited by 236
Pulte, D., Gondos, A., & Brenner, H. (2009) · Blood · doi:10.1182/blood-2008-06-164863 · Cited by 234
Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
Harrison, C. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07417.x · Cited by 216
Weston, B. W., Hayden, M. A., Roberts, K. G., Bowyer, S., Hsu, J., Fedoriw, G., Rao, K. W., & Mullighan, C. G. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.6770 · Cited by 213
Self-citationStage-specific control of early B cell development by the transcription factor Ikaros
Schwickert, T. A., Tagoh, H., Gültekin, S., Dakic, A., Axelsson, E., Minnich, M., Ebert, A., Werner, B., Roth, M., Cimmino, L., et al. (2014) · Nature Immunology · doi:10.1038/ni.2828 · Cited by 210
Pui, C.-H., Mahmoud, H. H., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Behm, F. G., Head, D. R., Relling, M. V., Ribeiro, R. C., Rubnitz, J. E., et al. (1998) · Blood · doi:10.1182/blood.v92.2.411 · Cited by 209
Pui, C.-H., Pei, D., Coustan-Smith, E., Jeha, S., Cheng, C., Bowman, W. P., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Inaba, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70082-3 · Cited by 207
Harrison, C. J., Moorman, A. V., Schwab, C., Carroll, A. J., Raetz, E. A., Devidas, M., Strehl, S., Nebral, K., Harbott, J., Teigler-Schlegel, A., et al. (2014) · Leukemia · doi:10.1038/leu.2013.317 · Cited by 204
Self-citationBhatia, S., Landier, W., Hageman, L., Kim, H., Chen, Y., Crews, K. R., Evans, W. E., Bostrom, B., Casillas, J., Dickens, D. S., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552166 · Cited by 203
Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children
Pui, C.-H. (2003) · JAMA · doi:10.1001/jama.290.15.2001 · Cited by 199
Nowak-Göttl, U., Wermes, C., Junker, R., Koch, H.-G., Schobess, R., Fleischhack, G., Schwabe, D., & Ehrenforth, S. (1999) · Blood · doi:10.1182/blood.v93.5.1595 · Cited by 198
Van der Meulen, J., Sanghvi, V., Mavrakis, K., Durinck, K., Fang, F., Matthijssens, F., Rondou, P., Rosen, M., Pieters, T., Vandenberghe, P., et al. (2015) · Blood · doi:10.1182/blood-2014-05-577270 · Cited by 195
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia
Relling, M., Yanishevski, Y., Nemec, J., Evans, W., Boyett, J., Behm, F., & Pui, C.-H. (1998) · Leukemia · doi:10.1038/sj.leu.2400928 · Cited by 188
Mattano, L. A., Devidas, M., Nachman, J. B., Sather, H. N., Hunger, S. P., Steinherz, P. G., Gaynon, P. S., & Seibel, N. L. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70274-7 · Cited by 181
Self-citationGenomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia
Lim, J. Y., Bhatia, S., Robison, L. L., & Yang, J. J. (2014) · Cancer · doi:10.1002/cncr.28531 · Cited by 180
Reaman, G. H., Sposto, R., Sensel, M. G., Lange, B. J., Feusner, J. H., Heerema, N. A., Leonard, M., Holmes, E. J., Sather, H. N., Pendergrass, T. W., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.445 · Cited by 179
Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL
Li, B., Li, H., Bai, Y., Kirschner-Schwabe, R., Yang, J. J., Chen, Y., Lu, G., Tzoneva, G., Ma, X., Wu, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3840 · Cited by 178
TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia
Seeger, K., Adams, H.-P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C., Ritter, J., Schwabe, D., Harms, D., Schrappe, M., et al. (1998) · Blood · doi:10.1182/blood.v91.5.1716 · Cited by 177
Chessells, J., Hall, E., Prentice, H., Durrant, J., Bailey, C., & Richards, S. (1998) · Leukemia · doi:10.1038/sj.leu.2400959 · Cited by 174
Kaspers, G. J. L., Pieters, R., Van Zantwijk, C. H., VanWering, E. R., Van Der Does-Van Den Berg, A., & Veerman, A. J. P. (1998) · Blood · doi:10.1182/blood.v92.1.259.413k21_259_266 · Cited by 168
Inherited genetic variation in childhood acute lymphoblastic leukemia
Moriyama, T., Relling, M. V., & Yang, J. J. J. (2015) · Blood · doi:10.1182/blood-2014-12-580001 · Cited by 167
Clappier, E., Mf, A., Rapion, J., Bakkus, M. H. C., Caye‐Eude, A., Khemiri, A., Giroux, C., Hernandez, L., Kabongo, E., Savola, S. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.277 · Cited by 162
Johansson, B., Moorman, A. V., Haas, O., Watmore, A., Cheung, K. L., Swanton, S., & Secker‐Walker, L. M. (1998) · Leukemia · doi:10.1038/sj.leu.2401012 · Cited by 148
Sex Differences in Prognosis for Children With Acute Lymphoblastic Leukemia
Pui, C., Boyett, J. M., Relling, M. V., Harrison, P. L., Rivera, G. K., Behm, F. G., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Gajjar, A. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.818 · Cited by 142
Heerema, N. A., Carroll, A. J., Devidas, M., Loh, M. L., Borowitz, M. J., Gastier, J. M., Larsen, E. C., Mattano, L. A., Maloney, K. W., Willman, C. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1308 · Cited by 136
Self-citationRots, M. G., Pieters, R., Peters, G. J., Noordhuis, P., van Zantwijk, C. H., Kaspers, G. J. L., Hählen, K., Creutzig, U., Veerman, A. J. P., & Jansen, G. (1999) · Blood · doi:10.1182/blood.v93.5.1677 · Cited by 134
Brennan, B. M. D., Rahim, A., Adams, J. E., Eden, O. B., & Shalet, S. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690296 · Cited by 132
Hill, J. M., Kornblith, A. B., Jones, D., Freeman, A. I., Holland, J. F., Glicksman, A. S., Boyett, J. M., Lenherr, B., Brecher, M. L., Dubowy, R. L., et al. (1998) · PubMed · doi:10.1002/(sici)1097-0142(19980101)82:1<208::aid-cncr26>3.0.co;2-5 · Cited by 129
Woo, M., Hak, L., Storm, M., Evans, W., Sandlund, J. T., Rivera, G. K., Wang, B., Pui, C., & Relling, M. V. (1998) · Leukemia · doi:10.1038/sj.leu.2401162 · Cited by 128
Rubnitz, J. E., Relling, M. V., Harrison, P., Sandlund, J. T., Ribeiro, R., Rivera, G. K., Thompson, S., Evans, W., & Pui, C.-H. (1998) · Leukemia · doi:10.1038/sj.leu.2401098 · Cited by 128
Nachman, J. B., Sather, H. N., Cherlow, J. M., Sensel, M. G., Gaynon, P. S., Lukens, J. N., Wolff, L. J., & Trigg, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.920 · Cited by 125
Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Stock, W. (2010) · Hematology · doi:10.1182/asheducation-2010.1.21 · Cited by 124
Gustafsson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J., Lie, S. O., Pj, M., Perkkiö, M. V., YSSING, M., Saarinen‐Pihkala, U., et al. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00923.x · Cited by 124
Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood
Brennan, Rahim, Mackie, Eden, & Shalet (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00438.x · Cited by 122
Incidence of TEL/AML1 Fusion in Children With Relapsed Acute Lymphoblastic Leukemia
Loh, M. L., Silverman, L. B., Young, M. L., Neuberg, D. S., Golub, T. R., Sallan, S. E., & Gilliland, D. G. (1998) · Blood · doi:10.1182/blood.v92.12.4792 · Cited by 119
Dördelmann, M., Schrappe, M., Reiter, A., Zimmermann, M., Graf, N. M., Schott, G., Lampert, F., Harbott, J., Niemeyer, C., Ritter, J., et al. (1998) · Leukemia · doi:10.1038/sj.leu.2400989 · Cited by 117
A study of “total therapy” of acute lymphocyticleukemia in children
George, P., Hernandez, K., Hustu, O., Borella, L. D., Holton, C. P., & Pinkel, D. P. (1968) · The Journal of Pediatrics · doi:10.1016/s0022-3476(68)80217-3 · Cited by 116
Childhood Acute Lymphoblastic Leukemia With the MLL-ENL Fusion and t(11;19)(q23;p13.3) Translocation
Rubnitz, J. E., Camitta, B. M., Mahmoud, H. H., Raimondi, S. C., Carroll, A. J., Borowitz, M. J., Shuster, J. J., Link, M. P., Pullen, D. J., Downing, J. R., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.191 · Cited by 116
The role of TEL fusion genes in pediatric leukemias
Rubnitz, J. E., Pui, C., & Downing, J. R. (1999) · Leukemia · doi:10.1038/sj.leu.2401258 · Cited by 114
Balis, F. M., Holcenberg, J. S., Poplack, D. G., Ge, J., Sather, H. N., Murphy, R. F., Ames, M. M., Waskerwitz, M. J., Tubergen, D. G., Zimm, S., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3569 · Cited by 112
Yotnda, P., Garcia, F., Peuchmaur, M. M., Grandchamp, B., Duval, M., Lemonnier, F. A., VILMER, E., & Langlade‐Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3126 · Cited by 111
PAX5 loss imposes a reversible differentiation block in b-progenitor acute lymphoblastic leukemia
Liu, G., Cimmino, L., Jude, J., Hu, Y., Witkowski, M. T., McKenzie, M. D., Kartal‐Kaess, M., Best, S. A., Tuohey, L., Liao, Y., et al. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.07.171 · Cited by 109
Self-citationKamps, W. A., Bökkerink, J. P. M., Hählen, K., Hermans, J., Riehm, H., Gadner, H., Schrappe, M., Slater, R. M., Ruiter, E. V. D. B.-D., Smets, L. A., et al. (1999) · PubMed · Cited by 107
Second malignancies in patients treated for childhood acute lymphoblastic leukemia.
Dalton, V. K., Gelber, R. D., Li, F., Donnelly, M. J., Tarbell, N. J., & Sallan, S. E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2848 · Cited by 105
Hogarth, L., & Hall, A. G. (1999) · Blood · doi:10.1182/blood.v93.8.2671 · Cited by 103
Ito, C., Kumagai, M., Manabe, A., Coustan‐Smith, E., Raimondi, S. C., Behm, F. G., Murti, K. G., Rubnitz, J. E., Pui, C., & Campana, D. (1999) · Blood · doi:10.1182/blood.v93.1.315 · Cited by 103
Gandhi, V. V., Plunkett, W. K., Rodriguez, C. O., Nowak, B. J., Du, M., Ayres, M., Kisor, D. F., Mitchell, B. S., Kurtzberg, J., & Keating, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3607 · Cited by 103
Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom, K., Holm, K., Michaelsen, K. F., HERTZ, H., Müller, J., & Mølgaard, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.12.3752 · Cited by 100
Silverman, L. B., McLean, T. W., Gelber, R. D., Donnelly, M. J., Gilliland, D. G., Tarbell, N. J., & Sallan, S. E. (1997) · PubMed · Cited by 100
Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Campana, D. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283543d5c · Cited by 97
Yeoh, A. E. J., Tan, D. C. L., Li, C. K., Hori, H., Tse, E., & Pui, C. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70452-2 · Cited by 95
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
Raetz, E. A., & Bhatla, T. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.129.3800156 · Cited by 90
Maloney, K. W., McGavran, L., Odom, L. F., & Hunger, S. P. (1999) · Blood · doi:10.1182/blood.v93.7.2380 · Cited by 84
Self-citationLarson, R. A., Fretzin, M., Dodge, R., & Schiffer, C. (1998) · Leukemia · doi:10.1038/sj.leu.2401007 · Cited by 83
Steinherz, P. G., Gaynon, P. S., Breneman, J. C., Cherlow, J. M., Grossman, N. J., Kersey, J. H., Johnstone, H. S., Sather, H. N., Trigg, M. E., Uckun, F. M., et al. (1998) · Cancer · Cited by 81
Domenech, C., Suciu, S., Moerloose, B. D., Mazingue, F., Plat, G., Ferster, A., Uyttebroeck, A., Sirvent, N., Lutz, P., Yakouben, K., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.103507 · Cited by 81
Rubnitz, J. E., Behm, F. G., Wichlan, D., Ryan, C., Sandlund, J. T., Ribeiro, R., Rivera, G. K., Hancock, M., Relling, M. V., Evans, W., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401257 · Cited by 80
Birkebæk, N., Fisker, S., Clausen, N., Tuovinen, V. J., Sindet‐Pedersen, S., & Christiansen, J. S. (1998) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199806)30:6<351::aid-mpo9>3.0.co;2-d · Cited by 79
Shuster, J. J., Wacker, P., Pullen, J., Humbert, J., Land, V. J., Mahoney, D. H., Lauer, S. J., Look, A. T., Borowitz, M. J., Carroll, A. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2854 · Cited by 78
Donadieu, J., Auclerc, M.-F., Baruchel, A., Leblanc, T. M., Landman‐Parker, J., Pérel, Y., Michel, G., Cornu, G., Bordigoni, P., Sommelet, D., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00818.x · Cited by 74
Surtees, R. A. H., Clelland, J. D., & Hann, I. M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1505 · Cited by 73
Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia
Birkebæk, N., & Clausen, N. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.2.161 · Cited by 64
Pinheiro, J. P. V., Ahlke, E., Nowak‐Göttl, U., Hempel, G., Müller, H.-J., Lümkemann, K., Schrappe, M., Rath, B., Fleischhack, G., Mann, G. B., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01192.x · Cited by 63
Takahashi, Y., Horibe, K., Kiyoi, H., Miyashita, Y., Fukuda, M., Mori, H., Nozaki, C., Hasegawa, S., Kawabe, T., Kato, K., et al. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199805000-00002 · Cited by 63
Asselin, B. L., Kreissman, S. G., Coppola, D. J., Bernal, S. D., Leavitt, P., Gelber, R. D., Sallan, S. E., & Cohen, H. J. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199901000-00003 · Cited by 61
Navarrete, M., Rossi, E., Brivio, E., Carrillo, J. M., Bonilla, M., Vásquez, R., Peña, A., Fú, L., Martínez, R., Espinoza, C. P., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24911 · Cited by 61
TEL/AML1 positivity in childhood ALL: average or better prognosis?
Zuna, J., Hrušák, O., Kalinová, M., Mužíková, K., Starý, J., Trka, J., & for the Czech Paediatric Haematology Working Group (1999) · Leukemia · doi:10.1038/sj.leu.2401256 · Cited by 61
Liang, D.-C., Hung, I., Yang, C.-P., Lin, K.-H., Chen, J.-S., Hsiao, T.-C., Chang, T.-T., Pui, C.-H., Lee, C., Lin, K.-S., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401260 · Cited by 45
Acute Lymphoblastic Leukemia in Infants
Pui, C., & Evans, W. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.438 · Cited by 35
Mekki, Y., Catallo, R., Bertrand, Y., Manel, A., Ffrench, P., Baghdassarian, N., Duhaut, P., Bryon, P., & Ffrench, M. (1999) · Leukemia · doi:10.1038/sj.leu.2401303 · Cited by 34
Hrušák, O., Trka, J., Zuna, J., Housková, J., Bartůňková, J., Starý, J., & for the Pediatric Hematology Working Group in the Czech Republic (1998) · Leukemia · doi:10.1038/sj.leu.2401072 · Cited by 29
Crofton, P. M., Ahmed, S. F., Wade, J. C., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00060-x · Cited by 27
Yetgin, S., Gürgey, A., Murat Tuncer, A., Çetin, M., Özbek, N., Şayli, T., Güler, E., Kara, A., Olcay, L., Duru, F., et al. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00003-4 · Cited by 26
Cited by
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Liu, Y., Easton, J., Shao, Y., Maciaszek, J., Wang, Z., Wilkinson, M. R., McCastlain, K., Edmonson, M., Pounds, S. B., Shi, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3909 · Cited by 918
Self-citationTumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
Ma, L., Hernandez, M. O., Zhao, Y., Mehta, M., Tran, B., Kelly, M., Rae, Z., Hernandez, J. M., Davis, J. L., Martin, S. P., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.007 · Cited by 844
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J., Hagiwara, K., Pelletier, S., Gingras, S., Berns, H., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0315-5 · Cited by 603
Self-citation(2007) · doi:10.1289/ehp.9023 · Cited by 591
Metadata
- Authors
- Hunger, S. P., & Mullighan, C. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-10-15
- Volume
- 373
- Issue
- 16
- Pages
- 1541-1552
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1801876107
- Cited by
- 2,204
- References
- 154
- FWCI
- 102.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.